MedTrace Logo

LED Therapy for Third Molar Surgery

NCT06640439 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-10-15

No results posted yet for this study

Summary

LED Therapy for third molar surgery

Conditions

  • Molar, Third
  • Photobiomodulation
  • Photobiomodulation Therapy
  • Third Molar Surgery

Interventions

DEVICE

photobiomodulation

830 nm LED was used to irradiate the post-extraction area

DRUG

Antibiotic

ibuprofen 0.3 g bid for 3 days, metronidazole 0.1 g tid, and cefaclor 0.375 g bid for 7 days after surgery

Sponsors & Collaborators

  • Huashan Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-14
Primary Completion
2025-02-14
Completion
2025-04-14

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06640439 on ClinicalTrials.gov